• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARMACEUTICALS INC. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARMACEUTICALS INC. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Arthralgia (2355); Swelling/ Edema (4577)
Event Date 10/04/2021
Event Type  Injury  
Event Description
I had a series of 3 weekly euflexxa injections.This caused my symptoms to worsen and my knee to swell.Also my tendons attaching to my knees are seriously inflamed.Six weeks later, i am unable to walk any distance or stand for very long without pain.I have pain all the time.Prior to the injection i did have some swelling, but i was able to hike 6 miles several times a week.Now i cannot even walk a mile and standing or normal household chores cause pain and serious swelling.Post knee surgery.Administered by surgeon and (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING PHARMACEUTICALS INC.
MDR Report Key12908638
MDR Text Key281593025
Report NumberMW5105687
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/29/2021
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received11/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
ARMOUR THYROID 30 MG DAILY ; CALCIUM
Patient Outcome(s) Other; Disability;
Patient Age64 YR
Patient SexFemale
Patient Weight60 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-